PUMA BIOTECHNOLOGY-AKTIE kaufen? Analysen, Kursziele & Empfehlungen zu A1J643
Puma Biotechnology, Inc.: Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium